Ralph Charlton
Director Técnico/Científico/I+D en SPRUCE BIOSCIENCES, INC. .
Fortuna: 41 031 $ al 31/05/2024
Origen de la red de primer grado Ralph Charlton.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
| Subsidiary | Pharmaceuticals: Major | 4 | |
| Public Company | Pharmaceuticals: Major | 3 | |
Ascendis Pharma, Inc.
1
| Subsidiary | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ralph Charlton a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Bridgewater College | College/University | Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| University of California, Irvine | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Doctorate Degree | |
AmeriCares Foundation, Inc.
 AmeriCares Foundation, Inc. Hospital/Nursing ManagementHealth Services AmeriCares is a nonprofit disaster relief and humanitarian aid organization which provides immediate response to emergency medical needs and supports long-term humanitarian assistance programs for all people around the world, irrespective of race, creed or political persuasion. The organization was founded in 1982 and is headquartered in Stamford, CT. | Hospital/Nursing Management | Director/Board Member | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | President | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Basic Supply Co., Inc.
 Basic Supply Co., Inc. Industrial MachineryProducer Manufacturing Basic Supply Co., Inc. engages in the distribution of school and office supplies. The company was founded on November 15, 1977 and is headquartered in Huntington, WV. | Industrial Machinery | Director/Board Member | |
Astellas US LLC
 Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Pharmaceuticals: Major | Chief Operating Officer | |
Illinois Biotechnology Industry Organization
 Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Miscellaneous Commercial Services | Director/Board Member | |
| BIOATLA, INC. | Biotechnology | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc. (United Kingdom)
 McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Investment Managers | Corporate Officer/Principal | |
SlideMagic Ltd.
 SlideMagic Ltd. Packaged SoftwareTechnology Services SlideMagic Ltd. engages in developing software for presentations. It develops ready-made PowerPoint templates and design app that allows to make presentations in the browser. The company was founded on September 14, 2003 and is headquartered in Tel Aviv, Israel. | Packaged Software | Director/Board Member | |
| National Sales Network | Director/Board Member | ||
| Boys & Girls Club of Trenton & Mercer County | Corporate Officer/Principal | ||
| Rady School of Management at UC San Diego | College/University | Masters Business Admin | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TytoCare Ltd.
 TytoCare Ltd. Packaged SoftwareTechnology Services TytoCare Ltd. develops handheld devices and telehealth platform. Its products include TytoHome, TytoPro and TytoClinic. The firm specializes in medical devices, digital health, consumer, home monitoring and mobile health. The company was founded by Dedi Gilad and Ofer Tzadik in 2012 and is headquartered in Netanya, Israel. | Packaged Software | Director/Board Member | |
| Brody School of Medicine | College/University | Corporate Officer/Principal | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Founder Director/Board Member | |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
Aristea Therapeutics, Inc.
 Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Plexium, Inc.
 Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| VIATRIS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOMX INC. | Biotechnology | Director/Board Member | |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 38 |
| Israel | 6 |
| Reino Unido | 5 |
| Irlanda | 2 |
| China | 2 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 12 |
| Finance | 4 |
| Technology Services | 3 |
| Health Services | 2 |
Operativa
| Director/Board Member | 154 |
| Corporate Officer/Principal | 48 |
| Independent Dir/Board Member | 44 |
| Private Equity Investor | 16 |
| President | 16 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Kathy LaPorte | 34 |
| Michael Grey | 32 |
| Dan Spiegelman | 25 |
| Tiba Aynechi | 24 |
| Dina Chaya | 23 |
| Bali Muralidhar | 20 |
| Niall O'Donnell | 17 |
| Anat Naschitz | 16 |
| Percival Barretto-Ko | 15 |
| Edward Williams | 13 |
| Camilla Simpson | 12 |
| Eduardo Bruno Martins | 10 |
| Rosh Dias | 10 |
| Kirk Ways | 7 |
| Samir Gharib | 7 |
- Bolsa de valores
- Insiders
- Ralph Charlton
- Conexiones Empresas
